Urelumab
Encyclopedia
Urelumab is a human monoclonal antibody designed for the treatment of cancer and solid tumors.
Urelumab was developed by Bristol-Myers Squibb
.
Urelumab was developed by Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb , often referred to as BMS, is a pharmaceutical company, headquartered in New York City. The company was formed in 1989, following the merger of its predecessors Bristol-Myers and the Squibb Corporation...
.